Polydatin ameliorates renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic mice

Food and Chemical Toxicology

Volumn 52, Issue , 2013, Pages 28-35

  Chen, Lvyi ^a   Lan, Zhou ^b   Lin, Qinxiong ^a   Mi, Xue ^a   He, Yingying ^a   Wei, Liuhong ^a   Lin, Yuanyuan ^a   Zhang, Yu ^a   Deng, Xukun ^a  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Inflammatory; Oxidative stress; Polydatin; Urate nephropathy; Uric acid

Indexed keywords

ALLOPURINOL; ANTIOXIDANT; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; POLYDATIN; PROSTAGLANDIN E2; PROTECTIVE AGENT; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PROTEIN EXPRESSION; RENAL PROTECTION; TREATMENT DURATION; URIC ACID BLOOD LEVEL; URIC ACID NEPHROPATHY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BODY WEIGHT; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FRUCTOSE; GLUCOSIDES; INFLAMMATION; INTERLEUKIN-1BETA; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED STRAINS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PROTECTIVE AGENTS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID; XANTHINE OXIDASE;

MUS;

EID: 84869875563     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.037     Document Type: Article

References (34)

1. Akarasereenont P., Bakhle Y.S., Thiemermann C., Vane J.R. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. Br. J. Pharmacol. 1995, 115:401-408.
2. Avram Z., Krishnan E. Hyperuricaemia-where nephrology meets rheumatology. Rheumatology (Oxford) 2008, 47:960-964.
3. Bainbrige S.A., Roberts J.M. Uric acid as pathogenic factor in preeclampsia. Placenta 2008, 29:S67-S72.
4. Beyaert R., Fiers W. Tumor necrosis factor and lymphotoxin. Cytokines 1998, 335-359. Academic Press, San Diego, CA. A.R. Mire-Sluis, R. Thorpe (Eds.).
5. Chen L.Y., Yin H.F., Lan Z., Ma S.W., Zhang C.F., Yang Z.L., Li P., Lin B.Q. Anti-hyperuricemic and nephroprotective effects of Smilax china L. J. Ethnopharmacol. 2011, 135:399-405.
6. Chen L.Y., Lan Z., Zhou Y.Q., Li F., Zhang X., Zhang C.F., Yang Z.L., Li P. Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats. Planta Med. 2011, 77:1769-1773.
7. Conger J.D. Acute uric acid nephropathy. Med. Clin. North Am. 1990, 74:859-871.
8. Du J., Sun L.N., Xing W.W., Huang B.K., Jia M., Wu J.Z., Zhang H., Qin L.P. Lipid-lowering effects of polydatin from polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 2009, 16:652-658.
9. Feig D.I., Rodriguez-Iturbe B., Nakagawa T., Johnson R.J. Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension. Hypertension 2006, 48:25-26.
10. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 1980, 106:207-212.
11. Hammer B., Link A., Wagner A., Bohm M. Fatal allopurinol-induced hypersensitivity in asymptomatic hyperuricemia syndrome. Dtsch. Med. Wochenschr. 2001, 126:1331-1334.
12. Han H.J., Lim M.J., Lee Y.J., Lee J.H., Yang I.S., Taub M. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappa B. Am. J. Physiol. Renal Physiol. 2007, 292:F373-F381.
13. Ho E., Bray T.M. Antioxidants, NF-κB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 1999, 222:205-213.
14. Johnson R.J., Segal M.S., Srinivas T., Ejaz A., Mu W., Roncal C., Sanchez-Lozada L.G., Gersch M., Rodriguez-Iturbe B., Kang D.H., Acosta J.H. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?. J. Am. Soc. Nephrol. 2005, 16:1909-1919.
15. Kanellis J., Feig D.I., Johnson R.J. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton) 2004, 9:394-399.
16. Kerem Z., Bilkis I., Flaishman M.A., Sivan L. Antioxidant activity and inhibition of alpha-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of israili rumex bucephalophorus L. J. Agric. Food Chem. 2006, 544:1243-1247.
17. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., Krotova K., Block E.R., Prabhakar S., Johnson R.J. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005, 67:1739-1742.
18. Lan Z., Liu J., Chen L., Fu Q., Luo J., Qu R., Kong L., Ma S. Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice. J. Ethnopharmacol. 2012, 141:386-395.
19. Lee J.I., Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 1998, 38:981-993.
20. Marklund S. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J. Biol. Chem. 1976, 251:7504-7507.
21. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
22. Miao Q., Wang S., Miao S., Wang J., Xie Y., Yang Q. Cardioprotective effect of polydatin against ischemia/reperfusion injury: roles of protein kinase C and mito K(ATP) activation. Phytomedicine 2011, 19:8-12.
23. Mihara M., Uchiyama M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
24. Nakagawa T., Tuttle K.R., Short R.A., Johnson R.J. Hypothesis: fructose- induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat. Clin. Pract. Nephrol. 2005, 1:80-86.
25. Nakagawa T., Hu H., Zharikov S., Tuttle K.R., Short R.A., Glushakova O., Ouyang X., Feig D.I., Block E.R., Herrera-Acosta J., Patel J.M., Johnson R.J. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol. 2006, 290:F625-F631.
26. Park C.H., Noh J.S., Yamabe N., Kang K.S., Tanaka T., Yokozawa T. Beneficial effect of 7-O-galloyl-D-sedoheptulose on oxidative stress and hepatic and renal changes in type 2 diabetic db/db mice. Eur. J. Pharmacol. 2010, 640:233-242.
27. Peng J., Xie X., Huang K., Huang J., Shen, Shen X., Liu P., Huang H. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells. Mol. Cell Endocrinol. 2012, 10.1016/j.mce.2012.06.008.
28. Quan H., Peng X., Liu S.W., Bo F., Yang L., Huang Z.Y., Li H.X., Chen X.M., Wu D. Differentially expressed protein profile of renal tubule cell stimulated by elevated uric acid using SILAC coupled to LC-MS. Cell Physiol. Biochem. 2011, 27:91-98.
29. Saeed R., Khan Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin. Exp. Nephrol. 2004, 8:75-88.
30. Sanchez-Lozada L.G., Tapia E., Avila-Casado C., Soto V., Franco M., Santamaria J., Nakagawa T., Rodriguez-Iturbe B., Johnson R.J., Her-rera-Acosta J. Mild hyperuricemia induces glomerular hypertension in normal rats. Am. J. Physiol. Renal Physiol. 2002, 283:F1105-F1110.
31. Sanchez-Lozada L.G., Tapia E., Santamaria J., Avila-Casado C., Soto V., Nepomuceno T., Rodriguez-Iturbe B., Johnson R.J., Herrera-Acosta J. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005, 67:237-247.
32. Short R.A., Tuttle K.R. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective. Semin. Nephrol. 2005, 25:25-31.
33. Wortmann R.L. Gout and hyperuricemia. Curr. Opin. Rheumatol. 2002, 14:281-286.
34. Zhao X., Shu G.W., Chen L.Y., Mi X., Mei Z.N., Deng X.K. A flavonoid component from Docynia delavayi (Franch.) Schneid represses transplanted H22 hepatoma growth and exhibits low toxic effect on tumor-bearing mice. Food Chem. Toxicol. 2012, 10.1016/j.fct.2012.05.039.